Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 561.30M | 586.50M | 622.20M | 594.30M | 398.60M |
Gross Profit | 249.70M | 245.80M | 247.60M | 239.00M | 156.10M |
EBITDA | 107.20M | 102.00M | 92.00M | 104.20M | 57.90M |
Net Income | 33.50M | 38.50M | 36.50M | 41.00M | 18.50M |
Balance Sheet | |||||
Total Assets | 993.00M | 978.80M | 1.03B | 1.03B | 699.80M |
Cash, Cash Equivalents and Short-Term Investments | 43.60M | 17.00M | 50.00M | 52.30M | 44.10M |
Total Debt | 172.80M | 166.30M | 216.20M | 218.00M | 71.80M |
Total Liabilities | 350.00M | 342.20M | 401.10M | 408.30M | 198.90M |
Stockholders Equity | 643.00M | 636.60M | 627.10M | 617.70M | 500.90M |
Cash Flow | |||||
Free Cash Flow | 79.50M | 63.10M | 43.10M | 40.30M | 28.20M |
Operating Cash Flow | 105.10M | 97.60M | 86.90M | 74.90M | 53.30M |
Investing Cash Flow | -27.90M | -28.50M | -44.00M | -270.50M | -26.30M |
Financing Cash Flow | -50.60M | -102.10M | -45.20M | 203.90M | -30.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £1.25B | 31.51 | 16.36% | 1.52% | 7.32% | -6.70% | |
74 Outperform | £134.25M | 8.43 | 16.03% | 515.15% | -6.20% | 83.31% | |
72 Outperform | £975.93M | 29.08 | 5.24% | 309.35% | -4.30% | -13.09% | |
70 Outperform | £263.55M | 74.94 | 1.63% | 354.95% | -6.12% | -86.98% | |
69 Neutral | £1.21B | ― | -2.02% | 253.50% | -5.23% | -301.98% | |
67 Neutral | €8.36B | 21.11 | 6.46% | 2.82% | 1.86% | -38.90% | |
67 Neutral | £154.56M | 15.52 | 9.56% | 294.34% | -1.81% | 15.19% |
Genuit Group plc announced that Martin Gisbourne, the Chief Strategy and Sustainability Officer, exercised a nil-cost option over 2,165 shares as part of a Long-Term Incentive Plan awarded in April 2022. This transaction, compliant with UK Market Abuse Regulation, involved selling sufficient shares to cover tax and national insurance liabilities, reflecting a strategic financial decision within the company’s executive management.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc announced a board change, with Louise Brooke-Smith stepping down as Non-Executive Director and designated Employee Engagement Non-Executive Director after six years of service. Bronagh Kennedy, a current Non-Executive Director, will assume the role of designated Employee Engagement Non-Executive Director effective 24 September 2025. This change aligns with the company’s governance practices and may impact its employee engagement strategies.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group PLC, a company involved in the manufacturing sector, announced the successful passing of all resolutions during its Annual General Meeting held on May 19, 2025. The resolutions included the approval of audited accounts, directors’ remuneration, the declaration of a final dividend, re-election of directors, and authorization for share allotment and market purchases. The outcomes reflect strong shareholder support, which may positively impact the company’s governance and strategic initiatives.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc has reported that its trading for the first four months of 2025 is in line with expectations, with an 8.5% increase in revenue compared to the previous year. The company has seen organic sales growth across its business units and has gained market share despite a competitive environment. Genuit is focusing on productivity improvements through the Genuit Business System and is well-positioned to navigate current economic uncertainties. The company remains confident in its ability to outperform the market over the medium term due to its strong focus on sustainability-linked growth drivers.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £525.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.